CCAT1/ANXA2/GSK3β activates the WNT/β-catenin signaling pathway by increasing the amount of nuclear β-catenin, which interacts with transcription factor 4 (TCF4), resulting in the migration and invasion of breast cancer [63]. The gene discussed is TCF4; the disease is breast carcinoma.